Clinical Efficacy of Dronabinol for PTSD Nightmares: Insights from a 171-Person Trial
A 171-person randomized controlled trial demonstrates dronabinol PTSD nightmares clinical efficacy, significantly reducing nightmare frequency and intensity. This FDA-approved synthetic THC medication offers targeted relief for PTSD-related nightmares…
Dronabinol Cuts PTSD Nightmares in a New Randomized Trial
Dronabinol PTSD nightmares: a randomized, placebo-controlled trial in more than 170 adults found nightly oral THC significantly reduced PTSD-related nightmares over 10 weeks. More than a third of treated patients became nightmare-free. Overall PTSD…
THC and Alzheimer’s Agitation
THC for Alzheimer’s agitation is drawing attention after a randomized placebo-controlled dronabinol trial reported short-term reductions in agitation scores. The study is clinically meaningful because dementia-related agitation can be devastating for…
What the Dronabinol Hydromorphone Knee Osteoarthritis Trial Really Shows
This dronabinol hydromorphone knee osteoarthritis trial tested whether combining a cannabinoid with an opioid improves pain relief. The results suggest limited benefit and important side effects. Here is how to interpret what the study truly shows.